Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,126 | 31 | 99.3% |
| Education | $14.65 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $401.13 | 4 | $0 (2018) |
| Horizon Therapeutics plc | $301.02 | 5 | $0 (2021) |
| Allergan Inc. | $249.44 | 3 | $0 (2019) |
| Amgen Inc. | $179.37 | 4 | $0 (2024) |
| RxSight Inc | $155.01 | 1 | $0 (2024) |
| Alcon Vision LLC | $136.93 | 3 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $126.73 | 1 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $122.22 | 1 | $0 (2018) |
| Johnson & Johnson Surgical Vision, Inc. | $110.43 | 2 | $0 (2020) |
| Sun Pharmaceutical Industries Inc. | $96.45 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $399.01 | 8 | Amgen Inc. ($179.37) |
| 2023 | $102.95 | 2 | Alcon Vision LLC ($102.95) |
| 2021 | $180.77 | 4 | Horizon Therapeutics plc ($180.77) |
| 2020 | $110.43 | 2 | Johnson & Johnson Surgical Vision, Inc. ($110.43) |
| 2019 | $265.04 | 3 | Allergan Inc. ($125.00) |
| 2018 | $626.47 | 8 | Novartis Pharmaceuticals Corporation ($197.88) |
| 2017 | $455.81 | 6 | Novartis Pharmaceuticals Corporation ($203.25) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR HANDPIECE, RXSIGHT INJECTOR CARTRIDGE | Food and Beverage | In-kind items and services | $155.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $120.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/30/2024 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Clearpath, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: Ophthalmology | ||||||
| 08/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.65 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/06/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/03/2023 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $43.72 | General |
| Category: Ophthalmology | ||||||
| 04/18/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $59.23 | General |
| Category: Ophthalmology | ||||||
| 12/10/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Education | In-kind items and services | $6.51 | General |
| Category: TEPEZZA | ||||||
| 08/26/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Education | In-kind items and services | $8.14 | General |
| Category: TEPEZZA | ||||||
| 08/05/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $83.06 | General |
| Category: TEPEZZA | ||||||
| 08/05/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $83.06 | General |
| Category: TEPEZZA | ||||||
| 01/14/2020 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Symfony IOL (Device) | Food and Beverage | In-kind items and services | $69.77 | General |
| Category: Optics | ||||||
| 01/08/2020 | Johnson & Johnson Surgical Vision, Inc. | Tecnis Toric 1-piece IOL (Device) | Food and Beverage | In-kind items and services | $40.66 | General |
| Category: Optics | ||||||
| 10/03/2019 | Horizon Therapeutics plc | — | Food and Beverage | In-kind items and services | $120.25 | General |
| 09/23/2019 | Allergan Inc. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/26/2019 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $19.79 | General |
| Category: Ophthalmology | ||||||
| 11/15/2018 | Omeros Corporation | Omidria (Drug) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Ophthalmology | ||||||
| 08/29/2018 | Novartis Pharmaceuticals Corporation | BROLUCIZUMAB (Drug) | Food and Beverage | In-kind items and services | $119.38 | General |
| 07/16/2018 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $91.11 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/16/2018 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/12/2018 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug) | Food and Beverage | In-kind items and services | $126.73 | General |
| Category: Ophthalmology | ||||||
| 04/15/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $122.22 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,630 | 1,777 | $700,031 | $180,825 |
| 2022 | 18 | 1,432 | 1,557 | $591,391 | $155,508 |
| 2021 | 19 | 1,411 | 1,526 | $575,727 | $153,224 |
| 2020 | 18 | 1,270 | 1,378 | $492,049 | $129,152 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92081 | Measurement of field of vision during daylight conditions, limited examination | Office | 2021 | 72 | 72 | $6,048 | $1,846 | 30.5% |
| 11440 | Removal of growth (0.5 centimeters or less) of the face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 14 | 18 | $6,365 | $1,708 | 26.8% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 33 | 37 | $3,774 | $1,220 | 32.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,948 | $947.36 | 32.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 17 | $2,346 | $713.25 | 30.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 398 | 408 | $125,256 | $35,224 | 28.1% |
| 66984 | Removal of cataract with insertion of lens | Facility | 2020 | 42 | 66 | $124,872 | $30,212 | 24.2% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2020 | 14 | 15 | $44,760 | $11,293 | 25.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 130 | 151 | $32,012 | $9,290 | 29.0% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2020 | 13 | 13 | $34,000 | $8,847 | 26.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 132 | 148 | $26,788 | $6,931 | 25.9% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 138 | 145 | $26,753 | $6,608 | 24.7% |
| 66821 | Removal of recurring cataract in lens capsule using laser | Facility | 2020 | 16 | 16 | $17,050 | $4,563 | 26.8% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 110 | 112 | $10,416 | $3,068 | 29.5% |
| 67840 | Removal of eyelid growth | Office | 2020 | 12 | 13 | $7,280 | $2,618 | 36.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2020 | 45 | 63 | $11,192 | $2,316 | 20.7% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 26 | 26 | $9,620 | $2,082 | 21.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 49 | 55 | $5,940 | $1,769 | 29.8% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 46 | 48 | $4,896 | $1,358 | 27.7% |
| 92081 | Measurement of field of vision during daylight conditions | Office | 2020 | 49 | 49 | $4,075 | $1,193 | 29.3% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 20 | 20 | $3,720 | $788.31 | 21.2% |
| 92002 | Eye and medical examination for diagnosis and treatment, new patient | Office | 2020 | 11 | 11 | $2,222 | $732.56 | 33.0% |
| 92285 | Photography of content of eyes | Office | 2020 | 19 | 19 | $1,197 | $258.59 | 21.6% |
About Dr. Prashanth Vallabhanath, MD
Dr. Prashanth Vallabhanath, MD is a Ophthalmology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386626372.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Prashanth Vallabhanath, MD has received a total of $2,140 in payments from pharmaceutical and medical device companies, with $399.01 received in 2024. These payments were reported across 33 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,126).
As a Medicare-enrolled provider, Vallabhanath has provided services to 5,743 Medicare beneficiaries, totaling 6,238 services with total Medicare billing of $618,709. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmic Plastic and Reconstructive Surgery
- Location Portland, OR
- Active Since 11/16/2005
- Last Updated 02/20/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1386626372
Products in Payments
- LUMIGAN (Drug) $249.44
- ILEVRO (Drug) $203.25
- TEPEZZA (Drug) $180.77
- TEPEZZA (Biological) $179.37
- RXSIGHT CONTACT LENS (Device) $155.01
- Rhopressa (Drug) $126.73
- VYZULTA (Drug) $122.22
- BROLUCIZUMAB (Drug) $119.38
- Bromsite (Drug) $96.45
- TearLab Osmolarity System (Device) $80.12
- SIMBRINZA (Biological) $78.50
- BESIVANCE (Drug) $75.99
- Tecnis Symfony IOL (Device) $69.77
- Clareon (Device) $59.23
- Rocklatan (Drug) $43.72
- Tecnis Toric 1-piece IOL (Device) $40.66
- ORA (Device) $39.09
- Omidria (Drug) $35.90
- HYDRUS Microstent (Device) $33.98
- BOTOX (Biological) $18.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Portland
James Rosenbaum, M.d, M.D
Ophthalmology — Payments: $293,531
Dr. Mark Pennesi, Md Phd, MD PHD
Ophthalmology — Payments: $185,243
Peter Francis, Md, MD
Ophthalmology — Payments: $156,902
Roger Dailey, Md, MD
Ophthalmology — Payments: $135,004
Dr. Brian Chan-Kai, M.d, M.D
Ophthalmology — Payments: $123,899
Dr. Mark Terry, Md, MD
Ophthalmology — Payments: $112,572